Details for New Drug Application (NDA): 015500
✉ Email this page to a colleague
NDA 015500 describes TOLINASE, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the TOLINASE profile page.
The generic ingredient in TOLINASE is tolazamide. There are six drug master file entries for this compound. Additional details are available on the tolazamide profile page.
The generic ingredient in TOLINASE is tolazamide. There are six drug master file entries for this compound. Additional details are available on the tolazamide profile page.
Summary for 015500
| Tradename: | TOLINASE |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | tolazamide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 015500
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
